Replay available

Minerva Neurosciences, Inc (NERV) Q3 2021 Earnings Call

Minerva Neurosciences, Inc (NASDAQ: NERV) Q3 2021 earnings conference call, held 2021-11-08. Replay captured from the company's public earnings webcast.

Mon, November 8, 2021 at 8:30 AMendedReplay
Minerva Neurosciences, Inc (NERV) Q3 2021 Earnings Call

Investor webinar replay

Latest press releases

Companies on this event

Featured Presenters

Andrew Sy

Analyst, Jefferies

Doug Russell

Analyst, HC Wainwright

Dr. Remy Lutringer

Executive Chairman and Chief Executive Officer

Fred Auerholm

Chief Financial Officer

Jeff Race

President

Tom Schrader

Analyst, BTIG

Jason Butler

Analyst, JMP Securities

Replay transcript excerpt

Welcome to the Minerva Neurosciences third quarter 2021 call. At this time, all participants are in a listen-only mode. There will be a question and answer session following today's prepared remarks. This call is being webcast live on the investor section of Minerva's website at ir.minervaneurosciences.com. As a reminder, today's call is being recorded. I would now like to turn the call over to Jeff Race, President of Minerva. Please proceed. Good morning. A press release with the company's third quarter 2021 financial results and business highlights became available at 7.30 a.m. Eastern Time today and can be found on the investor section of our website. Our quarterly report on Form 10Q was also filed electronically with the Securities and Exchange Commission this morning and can be found on the SEC's website at www.sec.gov. Joining me on the call today from Minerva are Dr. Remy Lutringer, Executive Chairman and Chief Executive Officer, and Mr. Fred Auerholm, Chief Financial Officer. Following our prepared remarks, we will open the call for Q&A. Before we begin, I'd like to remind you that today's discussion will include statements about the company's future expectations, plans, and prospects that constitute forward-looking statements for purposes of the safe harbor provisions under the Private Securities Litigation Reform Act of 1995. We caution that these forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially from those indicated. Those forward-looking statements are based on our current expectations and may differ materially from actual results due to a variety of factors that are more fully detailed under the caption risk factors in our filings with the SEC, including our quarterly report on Form 10-Q ...

More from Minerva Neurosciences, Inc